These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36466349)

  • 21. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
    Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
    Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology and Alzheimer's disease: what has been done and what to do.
    Ruozi B; Belletti D; Pederzoli F; Veratti P; Forni F; Vandelli MA; Tosi G
    Curr Med Chem; 2014; 21(36):4169-85. PubMed ID: 25039777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art.
    Mir Najib Ullah SN; Afzal O; Altamimi ASA; Ather H; Sultana S; Almalki WH; Bharti P; Sahoo A; Dwivedi K; Khan G; Sultana S; Alzahrani A; Rahman M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
    Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation.
    Ribarič S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine: A Promising Way to Manage Alzheimer's Disease.
    Khan NH; Mir M; Ngowi EE; Zafar U; Khakwani MMAK; Khattak S; Zhai YK; Jiang ES; Zheng M; Duan SF; Wei JS; Wu DD; Ji XY
    Front Bioeng Biotechnol; 2021; 9():630055. PubMed ID: 33996777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.
    Tosi G; Pederzoli F; Belletti D; Vandelli MA; Forni F; Duskey JT; Ruozi B
    Prog Brain Res; 2019; 245():57-88. PubMed ID: 30961872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
    Ailioaie LM; Ailioaie C; Litscher G
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders.
    Guo ZH; Khattak S; Rauf MA; Ansari MA; Alomary MN; Razak S; Yang CY; Wu DD; Ji XY
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease.
    Gong B; Ji W; Chen X; Li P; Cheng W; Zhao Y; He B; Zhuang J; Gao J; Yin Y
    Mini Rev Med Chem; 2022; 22(17):2260-2270. PubMed ID: 35156576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents.
    Nazem A; Mansoori GA
    J Alzheimers Dis; 2008 Mar; 13(2):199-223. PubMed ID: 18376062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomaterials in Alzheimer's disease treatment: a comprehensive review.
    Faiyaz M; Ganayee MA; Akhtar S; Krishnan S; Flora B; Dogra D; Jha NK; Chellappan DK; Negi P; Dua K; Kesari KK; Gupta PK
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):851-865. PubMed ID: 34719210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease.
    Woon CK; Hui WK; Abas R; Haron MH; Das S; Lin TS
    Curr Neuropharmacol; 2022; 20(8):1498-1518. PubMed ID: 34923947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
    Altinoglu G; Adali T
    Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.